07 JUL 2023 | IN | CuraTeQ Biologics enters into exclusive licence agreement with BioFactura, Inc to commercialise its...
Home / News / Pearce IP Blog
ALL BLOGS BY
Naomi Pearce
Good news for inventors of computer technologies – Perram J redefines manner of manufacture following Aristocrat
In this patent infringement/validity dispute, Hanwha failed to establish that REC infringed its “old Act” Australian patent No 2008323025, and its dependant ACL claims were dismissed.
The $325M Question | Commonwealth Disappointed in Landmark Appeal Court Damages Case
In this patent infringement/validity dispute, Hanwha failed to establish that REC infringed its “old Act” Australian patent No 2008323025, and its dependant ACL claims were dismissed.
BioBlast w/e 30 Jun 23
01 JUL 2023 | US | Organon and Samsung Bioepis announce launch of Hadlima®, biosimilar to AbbVie’s Humira®...
BioBlast w/e 23 Jun 23
22 JUN 2023 | JP | ASLAN enters strategic licence with Zenyaku Kogyo to exclusively develop and commercialise novel...
BREAKING NEWS: COMMONWEALTH SANOFI DAMAGES DECISION DELIVERED BY FULL COURT: Sanofi avoids damages payment to the Commonwealth in Clopidogrel decision
The Full Federal Court handed down its decision this morning in the longstanding dispute as to whether the...
Cannabidiol PBS listing expanded: Chiesi secures second PBS reimbursed indication for Epidyolex®
The PBS listing for Chiesi’s Epidyolex®, an oral cannabidiol, was expanded on 1 June 2023 to include treatment of...
‘Selection’ amendments allowable before Patent Office in failed BioNTech opposition
In this patent infringement/validity dispute, Hanwha failed to establish that REC infringed its “old Act” Australian patent No 2008323025, and its dependant ACL claims were dismissed.
BioBlast f/e 16 Jun 23
16 JUN 2023 | BR | Bio-Thera Solutions enter agreement for distribution of BAT2206 (ustekinumab biosimilar to...
I’ll cry about it later – Katy Perry appeals AU trade mark loss
Katy Perry has appealed a Federal Court decision handed down on 21 April 2023 by Markovic J in Australia (Taylor v...
No issue estoppel in Australian Patent Office proceedings
In this patent infringement/validity dispute, Hanwha failed to establish that REC infringed its “old Act” Australian patent No 2008323025, and its dependant ACL claims were dismissed.
BioBlast w/e 2 Jun 23
01 JUN 2023 | EU | New indication alert: EC approves Novartis’ Cosentyx® (secukinumab) for HS Novartis announced that...
Merck publishes new data on Keytruda® (pembrolizumab) in NSCLC and mesothelioma
Merck announced positive results in two studies evaluating Keytruda®, its anti-PD-1 therapy. Merck reported that...
Schlam dunk – Federal Court makes Norwich Pharmacal orders against third party new employer
Jackson J in Austin Engineering Pty Ltd v Podulova & Ors [2023] FCA 419 issued interlocutory Norwich Pharmacal...
Innovent and Merck enter agreement for BI351 (KRASG12C Inhibitor) with Erbitux® (cetuximab) for NSCLC
Innovent announced that it has entered into a clinical trial collaboration and supply agreement with Merck for a...
Coherus 85% discount for US launch of YUSIMRY® (biosimilar adalimumab) & partnership with Mark Cuban
Coherus announced it is launching YUSIMRY® (adalimumab-aqvh) biosimilar to AbbVie’s Humira®, in July 2023 with a list...